Report: AIDS drugs to top $10 billion by 2015

04/12/2007 | Reuters

Global sales of HIV/AIDS drugs could reach $10.6 billion by 2015, up from $7.1 billion in 2005, according to a report from market researcher Datamonitor. Drug companies may be pressured to cut prices in developing nations, but the West remains a lucrative and fast-growing market. Firms such as Merck, Pfizer, Gilead Sciences and Johnson & Johnson may benefit most from the market growth, the report said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ